Global Innovative Platforms Inc. (GIPL)
OTCMKTS
· Delayed Price · Currency is USD
0.520
0.00 (0.00%)
Apr 27, 2026, 4:00 PM EST
160.00% (1Y)
| Market Cap | 24.75M |
| Revenue (ttm) | 30.00K |
| Net Income (ttm) | -647.21K |
| Shares Out | 47.59M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 440 |
| Average Volume | 456 |
| Open | 0.510 |
| Previous Close | 0.520 |
| Day's Range | 0.510 - 0.520 |
| 52-Week Range | 0.110 - 2.900 |
| Beta | 9,553.28 |
| RSI | 43.50 |
| Earnings Date | May 15, 2026 |
About GIPL
Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was ... [Read more]
Industry Shell Companies
Sector Financials
Founded 2020
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol GIPL
Financial Performance
Financial StatementsNews
Global Innovative Platforms Announces Completion of First Phase of Breath Test Study for Early Heartworm Detection
New non-invasive diagnostic may identify heartworm months earlier than current methods New non-invasive diagnostic may identify heartworm months earlier than current methods
7 months ago - GlobeNewsWire